Dr. Lal PathLabs Limited announced that its Board of Directors will convene on July 24, 2026. The meeting will primarily focus on approving the unaudited financial results for the quarter ended June 30, 2026. Additionally, the Board will consider the declaration of an interim dividend, if any, for the financial year 2026-27. This follows up on a previous intimation dated June 29, 2026.
Board Meeting Announcement
Dr. Lal PathLabs Limited has issued a follow-up intimation regarding a Board of Directors meeting. This meeting, initially scheduled for June 29, 2026, has been rescheduled and will now take place on Friday, July 24, 2026. The primary agenda for this crucial meeting includes the consideration and approval of the company’s un-audited financial results, both standalone and consolidated, for the quarter that concluded on June 30, 2026.
Interim Dividend Consideration
In addition to the financial results, the Board of Directors will also deliberate on the declaration of an interim dividend for the ongoing financial year, 2026-27. This consideration is a key item on the agenda for the meeting scheduled on July 24, 2026. The company requests that this information be duly noted.
Source: BSE
